WeChat Mini Program
Old Version Features
Research Interests

Papers共 54 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CXCR4 Promotes Tumor Stemness Maintenance and CDK4/6 Inhibitors Resistance in ER-positive Breast Cancer
Qianfeng Shi,Wang Yang, Yiye Ouyang, Yujie Liu,Zijie Cai
Breast Cancer Researchno. 1 (2025): 1-1
Cited0Views0WOSBibtex
0
0
An Analysis for IDH-Mutant Grade 4 Astrocytoma Based on WHO CNS 5: Implication of Clinical Practice
Xianxin Qiu,Liping Liang,Lingchao Chen, Pengjie Hong, Wanzun Lin, Jiabing Liu,Zhirui Zhou,Wenjia Zhu, Tianqi Wu,Mingyuan Pan, Yihua Zhong, Jing Gao,Zhiyong Qin,Yang Wang
Annals of clinical and translational neurology (2025)
Cited0Views0WOSBibtex
0
0
唤醒开颅手术在脑功能区复发胶质瘤治疗中的初步研究
YAO Shu-jing,WANG Yang, YANG Rui-xin, YU Shan, WANG Yu-bao,BAI Hong-min
Chinese Journal of Contemporary Neurology and Neurosurgeryno. 3 (2025)
Cited0Views0Bibtex
0
0
MMP1-induced NF-κB Activation Promotes Epithelial–mesenchymal Transition and Sacituzumab Govitecan Resistance in Hormone Receptor-Positive Breast Cancer
Letian Chen, Yinghuan Cen, Keyang Qian,Wang Yang, Wenbin Zhou,Yaping Yang
Cell death & diseaseno. 1 (2025): 346-346
Cited0Views0WOSNATUREBibtex
0
0
Qualitative Study on the Characteristics and Dilemmas of Ehealth Literacy among Family Caregivers of Breast Cancer Patients
Chengcheng Guo,Yang Wang, Liting Dong, Juan Wu,Sijin Guo
Digital health (2025): 20552076251346240-20552076251346240
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 53

#Citation: 591

H-Index: 14

G-Index: 23

Sociability: 5

Diversity: 3

Activity: 13

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn